ZYME240517C15000
- 0.05
- 0.000.00%
Zymeworks Newsroom
Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Ratings for Zymeworks (NASDAQ:ZYME) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their recent r
Express News | HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Zymeworks Is Maintained at Overweight by Wells Fargo
Zymeworks Is Maintained at Overweight by Wells Fargo
Express News | Wells Fargo Maintains Overweight on Zymeworks, Lowers Price Target to $12
Zymeworks Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 33.33% Wells Fargo $14 → $12 Maintains Overweight 03/12/2024 55.56% Wells Fargo $12 → $14 Maint
Here's Why We're Not Too Worried About Zymeworks' (NASDAQ:ZYME) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a ne
Earnings Call Summary | Zymeworks(ZYME.US) Q1 2024 Earnings Conference
The following is a summary of the Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript:Financial Performance:Zymeworks reported a net loss of $31.7 million, or a loss of $0.42 per diluted share, for
Express News | Zymeworks, Inc. : Wells Fargo Cuts Target Price to $12 From $14
Buy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming Catalysts
Express News | Zymeworks Inc : Citigroup Cuts Target Price to $16 From $17
Zymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
Express News | Zymeworks Inc: Qtrly Shr Loss $0.42
Express News | Zymeworks: Cash Resources as of March 31, 2024 Combined With Anticipated Regulatory Milestone Payments Provides Projected Cash Runway Into 2H 2027
Zymeworks Files Automatic Mixed Securities Shelf
Zymeworks Touts Financial Health and R&D Progress
Express News | Zymeworks Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) pe
Zymeworks Inc Stresses Transparency in Investor Communications